Neurology News

Decreases in skeletal muscle mass are associated with cognitive decline in type 2 diabetes, particularly among older adults, according to a study published in Journal of Diabetes and Its Complications.

The FDA has accepted a new drug application from Acadia Pharmaceuticals Inc. for trofinetide, a synthetic analog of the amino‐terminal tripeptide of IGF-1 designed to treat core symptoms of Rett syndrome.

In this edition, new cannabinoids hold promise for medical applications; Theranica secures $45 million for migraine treatment device and more.

Revitalist Lifestyle and Wellness and Wake Network Inc. announced a joint venture to offer ketamine infusions in the U.S. and psilocybin clinical retreats internationally with a special focus on military veterans’ need for access.

LAS VEGAS — Chronic pain is not a straightforward disease, and the clinician must gather information from a variety of sources, a presenter said at PAINWeek 2022.

LAS VEGAS — CDC guidelines issued in response to the opioid crisis have led to many health care providers reducing or eliminating pain control with opioids, Paul J. Christo, MD, MBA, said at PAINWeek 2022.

The FDA has accepted a new drug application for aripiprazole, a 2-month, ready-to-use, long-acting injectable for the treatment of schizophrenia in adults and maintenance monotherapy treatment of bipolar I disorder in adults.

The daily use of multivitamin-mineral supplements improved global cognition, episodic memory and executive function in older adults, researchers reported in Alzheimer’s & Dementia: The Journal of The Alzheimer’s Association.

Cannabis use during pregnancy may place children at risk for attention, social and behavioral problems into early adolescence and mental health issues and substance use later on, according to research published in JAMA Pediatrics.

Amylyx Pharmaceuticals announced that the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee voted to support approval of the company’s oral, fixed-dose therapeutic AMX0035 for the treatment of ALS.